期刊
RHEUMATOLOGY
卷 57, 期 -, 页码 51-62出版社
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/kex423
关键词
targeted therapy; biologic therapy; giant cell arteritis; pathogenesis; treatment; inflammation; angiogenesis; vascular remodelling
类别
资金
- F Hoffmann-La Roche Ltd, Basel, Switzerland
- Ministerio de Economia, Industria y Competitividad [SAF 2014-57708-R, SAF 2017-88275-R]
GCA is a chronic granulomatous vasculitis that affects large- and medium-sized vessels. Both the innate and the adaptive immune system are thought to play an important role in the initial events of the pathogenesis of GCA. Amplification cascades are involved in the subsequent development and progression of the disease, resulting in vascular inflammation, remodelling and occlusion. The development of large-vessel vasculitis in genetically modified mice has provided some evidence regarding potential mechanisms that lead to vascular inflammation. However, the participation of specific mechanistic pathways in GCA has not been fully established because of the paucity and limitations of functional models. Treatment of GCA is evolving, and novel therapies are being incorporated into the GCA treatment landscape. In addition, to improve the management of GCA, targeted therapies are providing functional proof of concept of the relevance of particular pathogenic mechanisms in the development of GCA and in sustaining vascular inflammation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据